ARCHIVES

Study: Keytruda Improves PFS In Ipilimumab-Refactory Disease

This article is from The Cancer Letter archive.

Vol. 37 No. 11 | November 28, 2014

Download PDF Visit The Full Archive

Related Articles

Letter Protests Closed Meeting; NIH Calls Action Appropriate

August 12, 1994

NCI Stops Trial Of Screening In Men To Add Women

November 2, 1990

NCI Programs: NCI Seeks Nominations For director’s Consumer Liaison Group

August 6, 1999

Obey Attacks NCI In Campaign Speech

October 29, 1976

Avastin Phase III Trial Meets Endpoint: PFS in Platinum-Sensitive Ovarian Cancer

February 25, 2011

DCE Advisors Okay Study Of Cancer Risk in Breast Augmentation

November 22, 1991